Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Chronic lymphocytic leukemia.

Chiorazzi N, Rai KR, Ferrarini M.

N Engl J Med. 2005 Feb 24;352(8):804-15. Review. No abstract available.

PMID:
15728813
2.

Perspectives in chronic lymphocytic leukemia biology and management.

Dighiero G.

Hematol Oncol Clin North Am. 2004 Aug;18(4):927-43, x. Review.

PMID:
15325707
3.

Role of the microenvironment in chronic lymphocytic leukaemia.

Caligaris-Cappio F.

Br J Haematol. 2003 Nov;123(3):380-8. Review. No abstract available.

PMID:
14616995
4.

Chronic lymphocytic leukemia: new insights into biology and therapy.

Foon KA, Rai KR, Gale RP.

Ann Intern Med. 1990 Oct 1;113(7):525-39. Review.

PMID:
2203293
5.

Chronic lymphocytic leukemia: revelations from the B-cell receptor.

Stevenson FK, Caligaris-Cappio F.

Blood. 2004 Jun 15;103(12):4389-95. Epub 2004 Feb 12. Review.

6.

Chronic lymphocytic leukemia and hairy-cell leukemia.

Cheson BD.

Curr Opin Oncol. 1991 Feb;3(1):54-62. Review.

PMID:
1710506
7.

The chronic B-cell leukaemias.

Mulligan SP, Catovsky D.

Aust N Z J Med. 1993 Feb;23(1):42-50. Review. No abstract available.

PMID:
8460973
8.

[Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].

Rupniewska ZM, Wach M, Kowal M, Roliński J, Antosz H.

Acta Haematol Pol. 1992;23(1):21-7. Review. Polish.

PMID:
1615748
9.

Architecture of the human B-cell antigen receptors.

van Noesel CJ, van Lier RA.

Blood. 1993 Jul 15;82(2):363-73. Review. No abstract available.

10.

Autocrine regulation of normal and malignant B lymphocytes.

Gordon J, Cairns JA.

Adv Cancer Res. 1991;56:313-34. Review. No abstract available.

PMID:
1851375
11.

Vaccine- and immune-based therapy in chronic lymphocytic leukemia.

Le Dieu R, Gribben J.

Semin Oncol. 2006 Apr;33(2):220-9. Review.

PMID:
16616069
12.

Clinical staging and prognostic markers in chronic lymphocytic leukemia.

Rai KR, Wasil T, Iqbal U, Driscoll N, Patel D, Janson D, Mehrotra B.

Hematol Oncol Clin North Am. 2004 Aug;18(4):795-805, vii. Review.

PMID:
15325699
13.

Pathophysiologic mechanisms of chronic lymphocytic leukemia and their application to therapy.

Rai KR.

Exp Hematol. 2007 Apr;35(4 Suppl 1):134-6. Review. No abstract available.

PMID:
17379098
14.

Antigen receptors on T and B lymphocytes: parallels in organization and function.

Borst J, Brouns GS, de Vries E, Verschuren MC, Mason DY, van Dongen JJ.

Immunol Rev. 1993 Apr;132:49-84. Review. No abstract available.

PMID:
8349297
15.

Chronic lymphocytic leukemia with paraimmunoblastic transformation - with comparative genomic hybridization and review of the literature.

Chuang SS, Liao YL, Liou CP, Wiggins ML, Ye H, Du MQ, Isaacson PG, Chang CC.

Pathol Res Pract. 2010 Apr 15;206(4):276-81. doi: 10.1016/j.prp.2009.04.004. Epub 2009 May 10. Review.

PMID:
19433347
16.

Chronic lymphocytic leukaemia as an immunoproliferative disorder.

Brouet JC, Seligmann M.

Clin Haematol. 1977 Feb;6(1):169-84. Review. No abstract available.

PMID:
334408
17.

Chronic lymphocytic leukemia: the most common leukemia in adults.

Washburn L.

JAAPA. 2011 May;24(5):54-8 Quiz 59. Review. No abstract available.

PMID:
21574533
18.

[Gene therapy for hematological malignancies].

Ozawa K.

Nihon Rinsho. 2010 Aug;68 Suppl 8:619-22. Review. Japanese. No abstract available.

PMID:
20979309
19.

Prognostic factors in chronic lymphocytic leukemia.

Hallek M; German CLL Study Group.

Ann Oncol. 2008 Jun;19 Suppl 4:iv51-3. doi: 10.1093/annonc/mdn196. Review. No abstract available.

PMID:
18519404
20.

[Apoptosis in chronic lymphocytic leukemia].

Brajusković G, Milić AS, Vukosavić S, Romac S, Cerović S, Knezević-Usaj S, Popović L, Marjanović S, Dimitrijević J.

Vojnosanit Pregl. 2002 Nov-Dec;59(6 Suppl):47-52. Review. Serbian. No abstract available.

PMID:
12852146

Supplemental Content

Support Center